Mindbytes Sep 21, 2026
Europe Approves Obicetrapib in Two Cholesterol Treatments
Ubeslo and Evlarco secure the drug’s first authorization, while a study of cardiovascular outcomes continues.
Hruy
Follow the subjects shaping intelligence, science, culture, and the future of technology.
Find a subject, then follow its latest reporting and ideas.
Recent stories, interviews, and analysis in this subject.